View of Comparison of Major Molecular Responses Achieved at 12 Months with Imatinib Versus Newer Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome Positive Chronic Myeloid Leukemia Patients: A Systematic Umbrella Review and a Meta-analysis

Return to Article Details Comparison of Major Molecular Responses Achieved at 12 Months with Imatinib Versus Newer Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome Positive Chronic Myeloid Leukemia Patients: A Systematic Umbrella Review and a Meta-analysis Download Download PDF